Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 181 AL 195

Dysregulated mTOR-dependent signaling in neurodegeneration or carcinogenesis: implication for Alzheimer's disease and brain tumors

Wang S, Wu J, Nie SD, Bereczki E, Pei JJ.

J Alzheimers Dis. 2013;37(3):495-505. doi: 10.3233/JAD-130641.

Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease

Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR.

Dement Geriatr Cogn Disord. 2013;36(3-4):242-50. doi: 10.1159/000351671. Epub 2013 Aug 15.

Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies

Liu YH, Zeng F, Wang YR, Zhou HD, Giunta B, Tan J, Wang YJ.

Drug Discov Today. 2013 Dec;18(23-24):1212-20. doi: 10.1016/j.drudis.2013.07.020. Epub 2013 Aug 13.

Overload of families taking care of elderly people with Alzheimer's Disease: a comparative study

Borghi AC, de Castro VC, Marcon SS, Carreira L.

Rev Lat Am Enfermagem. 2013 Jul-Aug;21(4):876-83. doi: 10.1590/S0104-11692013000400007.

Human Vaccines & Immunotherapeutics. Letter from the editor

Ellis R, Riedmann EM.

Hum Vaccin Immunother. 2013 Aug;9(8):1609-10. doi: 10.4161/hv.26188. Epub 2013 Aug 1.

SUMO and Alzheimer's disease

Lee L, Sakurai M, Matsuzaki S, Arancio O, Fraser P.

Neuromolecular Med. 2013 Dec;15(4):720-36. doi: 10.1007/s12017-013-8257-7. Epub 2013 Aug 25.

Efficacy of higher dose 13.3 mg/24 h rivastigmine patch on instrumental activities of daily living in patients with mild-to-moderate Alzheimer's disease

Grossberg G, Cummings J, Frölich L, Bellelli G, Molinuevo JL, Krahnke T, Strohmaier C.

Am J Alzheimers Dis Other Demen. 2013 Sep;28(6):583-91. doi: 10.1177/1533317513495104.

Oxidative stress and the pathogenesis of Alzheimer's disease

Zhao Y, Zhao B.

Oxid Med Cell Longev. 2013;2013:316523. doi: 10.1155/2013/316523. Epub 2013 Jul 25.

[Role of glycogen synthase kinase-3 in mechanisms of learning and memory]

Grigoryan GA.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2013 Sep-Oct;63(5):507-19. doi: 10.7868/s0044467713050043.

The therapeutics of Alzheimer's disease: where we stand and where we are heading

Selkoe DJ.

Ann Neurol. 2013 Sep;74(3):328-36. doi: 10.1002/ana.24001.

Memantine-associated hyperkalaemia in a patient with Alzheimer's disease

Tsukamoto T, Yamada H, Uchimura N.

Psychogeriatrics. 2013 Sep;13(3):180-1. doi: 10.1111/psyg.12022.

Clinical symptoms and symptom signatures of Alzheimer's disease subgroups

Iqbal K, Flory M, Soininen H.

J Alzheimers Dis. 2013;37(3):475-81. doi: 10.3233/JAD-130899.

Psychometric assessment of the depressive cognition scale in caregivers of persons with dementia

Bekhet AK, Zauszniewski JA.

Issues Ment Health Nurs. 2013 Sep;34(9):678-84. doi: 10.3109/01612840.2013.794180.

Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase

Hoos MD, Richardson BM, Foster MW, Everhart A, Thompson JW, Moseley MA, Colton CA.

J Proteome Res. 2013 Oct 4;12(10):4462-77. doi: 10.1021/pr4005103. Epub 2013 Sep 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias